Thromb Haemost 1961; 6(01): 104-117
DOI: 10.1055/s-0038-1654544
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Glas Effect and Platelet Activity in Hageman Plasma

Preben Ollendorff
1   Biological Institute of the Carlsberg Foundation, Copenhagen, Denmark
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Summary

After addition of a suspension of normal platelets the coagulation defect in Hageman plasma was corrected. The recalcification time became nearly normal and it was possible to activate the plasma by treatment with glass.

Hageman serum was unable to accelerate thromboplastin activation in normal plasma. After addition of a platelet suspension and exposure to glass the Hageman serum became as active as normal serum treated in the same way.

The results suggest that the Hageman trait might be caused by the presence of an excess of an inhibitor against glass activation and not by a deficiency in a clotting factor.

A study of previously published data on the Hageman trait shows that it is possible to explain many observations by the presence of such an inhibitor.

 
  • References

  • (1) Astrup T, Ollendorff P. Estimation of thromboplastin activation in plasma. Scand. J. clin. Lab. Invest.. 13. 1961
  • (2) Astrup T, Sjølin K.-E. Defects in Blood Coagulation. Dan. med. Bull. 4: 164-168 1957;
  • (3) Biggs R, Sharp A. A, Margolis J, Hardisty R. M, Stewart J, Davidson W. M. Defects in the Early Stages of Blood Coagulation: A Report of four Cases. Brit. J. Haem. 4: 177-191 1958;
  • (4) Frick P. G, Hagen P. S. Severe Coagulation Defect without Haemorrhagic Symptoms Caused by a Deficiency of the Fifth Plasma Thromboplastin Precursor. J. Lab. clin. Med. 47: 592-601 1956;
  • (5) Hardisty R. M, Margolis J. The Role of Hageman Factor in the Initiation of Blood Coagulation. Brit. J. Haemat. 5: 203-211 1959;
  • (6) Jim R. T. S, Goldfein S. Hageman Trait (Hageman Factor Deficiency). Amer. J. Med. 23: 824-831 1957;
  • (7) Johnston Jr Ch. L, Ferguson J. H, O’Hjnlon F. A. Surface Activation of Plasma Clotting: A Function of Hageman Factor. Proc. Soc. exp. Biol. (N. Y.) 99: 197-201 1958;
  • (8) Larrieu M. J, Soulier J.-P, Culot Y. Déficit en Facteur Hageman. Sang 28: 152-159 1957;
  • (9) Margolis J. Plasma Pain-Producing Substance and Blood Clotting. Nature 180: 1464-1465 1957;
  • (10) Margolis J. Activation of Plasma by Contact with Glass: Evidence for a Common Reaction which releases Plasma Kinin and Initiates Coagulation. J. Physiol. 144: 1-22 1958;
  • (11) Margolis J. The Kaolin Clotting Time. J. clin. Path. 11: 406-409 1958;
  • (12) Margolis J. Hageman Factor in Plasma Foreign Surface Reactions. Nature 182: 1102-1103 1958;
  • (13) Margolis J. Hageman Factor and Capillary Permeability. Aust. J. exp. Biol. 37: 239-244 1959;
  • (14) Ollendorff P. Defects in and Variability of the Thromboplastic System in Horse Plasma. Thromb. Diath. haem. 4: 45-55 1959;
  • (15) Ollendorff P. Initiation of Clotting in Normal and Hageman Plasma by Glass. Nature 186: 173-174 1960;
  • (16) Ollendorff P. Platelet Activity and Activation of Blood Clotting by Glass. Thromb. Diath. haem. 4: 410-423 1960;
  • (17) Ramot B, Singer K, Heller P, Zimmermann H. J. Hageman Factor Deficiency. Blood 11: 745-752 1956;
  • (18) Ratnoff O. D. A Familial Trait Characterized by Deficiency of a Clot-Promoting Fraction of Plasma. J. lab. Clin. Med. 44: 915-916 1954;
  • (19) Ratnoff O. D. Mechanism of Blood Coagulation. Connective Tissue, Thrombosis, and Arteriosclerosis. 213-222 Academic Press; New York, London: 1959
  • (20) Ratnoff O. D, Colopy J. E. A Familial Hemorrhagic Trait associated with a Deficiency of a Clot-promoting Fraction of Plasma. J. clin. Invest. 34: 602-613 1955;
  • (21) Ratnoff O. D, Margolius Jr A. Hageman Trait: An Asymptomatic Disorder of Blood Coagulation. Transaction of the Association of American Physicians LXVIII: 149 1955;
  • (22) Ratnoff O. D, Rosenblum J. M. The Role of Hageman Factor in the Initiation of Clotting by Glass. J. Lab. clin. Med. 50: 941-942 1957;
  • (23) Ratnoff O. D, Rosenblum J. M. Role of Hageman Factor in the Initiation of Clotting by Glass. Evidence that Glass Frees Hageman Factor from Inhibition. Amer. J. Med. 25: 160-168 1958;
  • (24) Sjølin K.-E. Deficiency of the Hageman Factor Demonstrated by the Thrombin Generation Test. Thromb. Diath. haem. 1: 153-157 1957;
  • (25) Sjølin K.-E. The Hageman Trait in a Family with Haemorrhagic Diathesis. Acta genet. (Basel) 7: 541-548 1957;
  • (26) Sjølin K.-E. Coagulation Defect in Horse Plasma. Proc. Soc. exp. Biol (N Y) 94: 818-820 1957;
  • (27) Soulier J.-P, Larrieu M. J. Deficit en 3’eme facteur prothromboplastiaue plasmatique. Rapport entre le PTA et le facteur Hageman. Thromb. Diath. haem. 2: 1-23 1958;
  • (28) Soulier J.-P, Prou-Wartelle O. New Data on Hageman Factor and Plasma Thromboplastin Antecedent: The Role of “Contact” in the Initial Phase of Blood Coagulation. Brit. J. Haemat. 6: 88-101 1960;
  • (29) Soulier J.-P, Prou-Wartelle O. Nouvelles Données sur les Facteur Hageman et PTA et sur le “Contact”. Rev. franç. Ét. clin. biol. 4: 932-938 1960;
  • (30) Soulier J.-P, Wartelle O, Ménaché D. Hageman Trait and PTA Deficiency; the Role of Contact of Blood with Glass. Brit. J. Haemat. 5: 121-138 1959;
  • (31) Vroman L. Surface Contact on Thromboplastin Formation. Thesis Utrecht: 1958
  • (32) Wartelle O. Mechanisme de la coagulation chez la poule. I. Etudes des éléments du “complexe prothrombique” et de la thromboplastinoformation. Rev. Hémat. 12: 351-387 1957;